Navigation Links
Boehringer Ingelheim and Xencor Enter a Collaboration Agreement for the Development, Manufacture, and Supply of Biosuperior Monoclonal Antibodies
Date:2/21/2012

13 potentially resulting in key human pharmacokinetic data validating Xtend technology.

About Xencor, Inc.

Xencor, Inc. engineers superior biotherapeutics using its proprietary Protein Design Automation® technology platform, and is a leader in the field of antibody engineering to significantly improve antibody half-life, immune-regulatory function and potency. The company is advancing multiple XmAb® antibody drug candidates in the clinic, including XmAb®5871 targeting CD32b and CD19 for autoimmune diseases, and an anti-CD30 candidate XmAb®2513 for the treatment of Hodgkin's lymphoma. Xencor is also advancing a portfolio of biosuperior versions of blockbuster antibody drugs engineered for superior half-life and dosing schedule. Xencor has entered into multiple partnerships with industry leaders such as Amgen, Pfizer, Centocor, MorphoSys, Boehringer Ingelheim, CSL Ltd. and Human Genome Sciences. In these partnerships Xencor is applying its suite of proprietary antibody Fc domains to improve antibody drug candidates for traits such as sustained half-life and/or potency. For more information, please visit www.xencor.com.

About Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates in 50 countries and more than 42,000 employees. Since it was founded in 1885, the family-owned company has been committed for 125 years to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

Today, Boehringer Ingelheim is one of the world's leading companies for contract development and manufacture of biopharmaceuticals. All types of services from mammalian cell line or microbial strain development to final drug production can be delivered within a one-stop-shop concept. Boehringer
'/>"/>

SOURCE Xencor, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CompleGen Announces Successful Delivery of Its XenoGene™ Technology to Boehringer Ingelheim for Drug Discovery Under a Non-Exclusive Agreement.
2. AbGenomics International, Inc. Regains Global Rights to AbGn-168H from Boehringer Ingelheim
3. Boehringer Ingelheim Invests More Than $350 Million in 2011 U.S. Expansion Projects
4. Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheims Two Investigational HCV Direct Acting Antivirals Presented at AASLD
5. Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes
6. Boehringer Ingelheim Broadens Its Breast Cancer Clinical Trial Program for the Investigational Compound Afatinib
7. Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves
8. Boehringer Ingelheim and Ashokas Changemakers Launch "Making More Health" Competition
9. Ashoka and Boehringer Ingelheim Announce a Global Partnership for "Making More Health"
10. Zealand Pharma and Boehringer Ingelheim Enter Into a Licence and Collaboration Agreement to Advance Novel Compounds to Treat Type-2 Diabetes and Obesity
11. Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... -- Future Prospects for Companies in Antihistamines, ... drugs - new study showing you trends, partnerships, ... for allergic rhinitis drugs heading? What are the commercial ... shows you potential revenues and other trends to 2025, ... page report provides 273 tables, charts, and graphs. Discover ...
(Date:9/4/2015)... , Sep. 04, 2015 ... the addition of the "Stability Testing of Pharmaceuticals ... their offering. By attending this comprehensive two ... to design efficient stability studies that are suitable for ... appropriate stability studies and manage stability samples and facilities ...
(Date:9/3/2015)... , Sept. 3, 2015 ... of New Drugs, Industry Changes and Emerging Opportunities ... human ovaries? Visiongain,s new study forecasts those pharmaceutical ... in that industry. You also explore trends, results, ... Our report gives revenue predictions to 2025 at ...
Breaking Medicine Technology:Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Stability Testing of Pharmaceuticals: 2 Day Seminar - London, UK - December 2-3, 2015 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 4Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 6
... Kessler Foundation ( www.kesslerfoundation.org ) and Kessler Institute ... rehabilitation centers in the U.S. to implement the ... designed to improve mobility in individuals with  spinal ... other neurological diseases. This new system, developed by ...
... Company (NYSE: LLY ) announced that it has ... The donation will enable expansion of the foundation,s patient services ... support of a new fund for patients with nonsquamous non-small ... cancer.   PAF is a national, non-profit organization ...
Cached Medicine Technology:Kessler is the First Rehabilitation Center in the Nation to Use New Robotic Gait Training System 2Kessler is the First Rehabilitation Center in the Nation to Use New Robotic Gait Training System 3Lilly Donation to Patient Advocate Foundation Expands Services and Access for Patients With Most Common Form of Lung Cancer 2Lilly Donation to Patient Advocate Foundation Expands Services and Access for Patients With Most Common Form of Lung Cancer 3
(Date:9/4/2015)... ... ... IVF New England, one of the largest and most successful fertility centers in the ... who wish to learn more about their fertility and egg freezing. , Date and ... Manchester, NH from 6PM to 7PM , This hip, casual and informative event will ...
(Date:9/4/2015)... ... September 04, 2015 , ... Scalability Experts (SE) announced ... awards at this year’s Microsoft Worldwide Partner Conference that was held in Orlando, ... Award Winner for Data Platform services, the 2015 HP and Microsoft “Outstanding Frontline ...
(Date:9/4/2015)... ... ... Many consumers are looking for a quick and convenient way to produce a hot remedy ... Cups provide a quick and simple way to brew a hot cup of cold remedy ... a result, they enhance comfort and health. The invention features a novel design that is ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... its first neighborhood created specifically for adults with intellectual, developmental and acquired disabilities. ... area and feature 30 cottage or “pocket” homes. In this community, adults will ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... a Labor Day offer that cannot be passed up. FiltersFast.com, will ship ... necessary air and water filtration product replacements. Take advantage of this promotion now ...
Breaking Medicine News(10 mins):Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2
... The Department of Health and Human Services recently awarded ... for achieving a lifesaving organ donation conversion rate of ... The award was given during the fourth National ... "Everyday, the doctors, nurses and staff at Jefferson Hospital ...
... cells of the connective tissue", whose activation exacerbates allergic ... of innate immunity as well as modulators of adaptive ... gastrointestinal mucosa is not only to react to antigens, ... properties of the intestinal epithelium. In clinical studies, it ...
... injury caused by ischemia/reperfusion (I/R) has been proposed ... transplantation and major liver surgery. The production of ... and hydroxyl radical, has been demonstrated in reperfusion ... biologic effects such as a potent antioxidative effect ...
... grow human blood platelets in the laboratory for transfusion, ... University Medical Center. , The findings, published in the ... Hematology , might one day enable blood banks to ... the chronically tight supply of these critical blood components. ...
... 2 dozen contain dangerous ingredients not listed on label ... Food and Drug Administration warned consumers Monday to avoid ... because they contain undeclared ingredients that could pose serious ... retail stores and on the Internet and some claim ...
... to protect the animals from smoke,s harmful effects, researchers ... experiments in mice, scientists have shown that a new ... caused by cigarettes. , The finding holds out hope ... a chronic progressive lung disease involving both emphysema and ...
Cached Medicine News:Health News:Jefferson Hospital for Neuroscience receives Department of Health and Human Services award 2Health News:What is the effect of fluoxetine on mast cell? 2Health News:Bioreactors might solve blood-platelet supply problems 2Health News:FDA Warns About Weight Loss Products 2Health News:FDA Warns About Weight Loss Products 3Health News:Drug Shields Mice From Emphysema 2
... Recommended for aqueous samples of moderate viscosity and density. Proven ergonomic ... greasing. Volume Range (ul) ... 2~5 Imprecision(%) ... Precision (ul) ...
... Finnpipette Digital offers improved ergonomics for ... handle, modified grippy finger rest and ... comfort and efficiency. Finnpipette Digitals also ... gearing mechanism (pat. pend.) and super ...
... Pipetman Ultra is a fully adjustable, air-displacement ... It is the latest member of the ... characteristics: robustness, accuracy, and precision. We also ... feedback from our customers. Eight models cover ...
Developed specifically for the 5000/5500 ultrasound consoles....
Medicine Products: